Sleeve banding combines two bariatric procedures: the gastric sleeve and an adjustable gastric band. It is a less common technique used to enhance the weight-loss results of the sleeve by adding additional restriction through the band. However, complications from the band have made it less favorable in recent years.

In the UK, slimming tablets are commonly prescribed or available over the counter to aid weight loss. Medications like Orlistat help block the absorption of fat, while appetite suppressants target hunger. These medications are often combined with lifestyle changes for better long-term results.

Endoscopic Sleeve Gastroplasty (ESG) is a non-surgical weight-loss procedure where a gastroenterologist uses an endoscope to stitch the stomach into a smaller size, reducing its capacity. Unlike traditional bariatric surgery, ESG is performed through the mouth and doesn’t involve cutting or removing any part of the stomach. Recovery is quicker, and the procedure is reversible, but the weight loss achieved is typically less significant than with RNY or gastric sleeve surgery.

Weight loss pills include prescription medications like Orlistat (which blocks fat absorption) and over-the-counter supplements marketed to boost metabolism or suppress appetite. While some medications are effective when used correctly, they must be combined with lifestyle changes like diet and exercise for long-term success.

A bowel specialist, or gastroenterologist, diagnoses and treats diseases of the digestive tract, including the stomach, intestines, and colon. Common conditions treated include IBS, Crohn’s disease, ulcerative colitis, and colon cancer.

Gastric RNY, or Roux-en-Y gastric bypass, remains one of the most effective surgical options for treating obesity. By reducing the size of the stomach and bypassing a portion of the intestines, patients experience a significant reduction in hunger and an inability to eat large meals. Gastric RNY can lead to rapid weight loss and improvement or resolution of obesity-related conditions such as type 2 diabetes, sleep apnea, and hypertension.

Weight-loss injections like Saxenda or Wegovy are available in Turkey as part of weight management programs. These injections help control appetite and promote weight loss by regulating hunger hormones. They are often prescribed to patients with obesity or related health conditions who have not been successful with diet and exercise alone.

Gastritis is inflammation of the stomach lining, while Irritable Bowel Syndrome (IBS) affects the intestines and causes chronic discomfort without inflammation. While both conditions involve digestive issues, gastritis typically causes nausea and upper abdominal pain, whereas IBS presents with bloating, diarrhea, or constipation.

The "Skinny Pen" refers to a weight-loss medication called liraglutide (brand name Saxenda) that is administered through a daily injection. It works by mimicking a hormone that regulates appetite, helping patients feel fuller for longer. This treatment is often used for individuals who struggle with obesity but are not candidates for surgery or who need additional help in managing their weight post-bariatric surgery. The drug is available by prescription and is used in conjunction with diet and exercise.

The NHS in the UK has started prescribing Wegovy to patients who struggle with obesity and have failed to achieve significant weight loss through diet and exercise. This medication is part of a broader initiative to provide patients with additional tools to combat the obesity epidemic. Wegovy is typically prescribed alongside lifestyle changes to maximize its effectiveness.